A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
Clinical trial NCT02100696 · COMPLETED
Trial details
- NCT number
- NCT02100696
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-21
- Primary completion
- 2020-04-16
- Enrollment
- 609
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.